Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

China · Delayed Price · Currency is CNY

33.46

+0.27 (0.81%)

Feb 27, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biopharma	168.14M	157.70M	158.65M	185.75M	-
Biopharma Growth	6.62%	-0.59%	-14.59%	-	-
Other	11.26M	5.08M	9.85M	45.39M	-
Other Growth	121.69%	-48.43%	-78.30%	-	-
Production and Sales of Raw Materials and Pharmaceutical Intermediates	53.41M	48.80M	200.72M	102.26M	-
Production and Sales of Raw Materials and Pharmaceutical Intermediates Growth	9.44%	-75.69%	96.29%	-	-
Medical Technical Services Reporting Segment	439.59M	390.70M	319.40M	281.29M	-
Medical Technical Services Reporting Segment Growth	12.51%	22.32%	13.55%	-	-
in Vitro Diagnostic Reagents	4.96M	-	-	-	-
offset of business segment	-28.39M	-	-	-	-
Total	648.97M	602.28M	688.63M	614.68M	-
Total Growth	7.75%	-12.54%	12.03%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	645.31M	602.23M	684.49M	605.73M	524.12M
China Growth	7.15%	-12.02%	13.00%	15.57%	-15.49%
Overseas	3.66M	58.90K	4.13M	8.96M	-
Overseas Growth	6121.16%	-98.58%	-53.86%	-	-
Total	648.97M	602.28M	688.63M	614.68M	524.12M
Total Growth	7.75%	-12.54%	12.03%	17.28%	-15.49%

Source: S&P Global Market Intelligence.